In renal cell carcinoma, the PI3K/Akt/mTOR signaling pathway is activated to regulate the epithelial–mesenchymal transition process, and matrix metalloproteinase 2 (MMP2) and MMP9 are also involved. Here, MMP2 is linked to hereditary clear cell renal cell carcinoma.